Welcome to our dedicated page for Celanese Del news (Ticker: CE), a resource for investors and traders seeking the latest updates and insights on Celanese Del stock.
Celanese Corp Del (CE) delivers essential chemical solutions and specialty materials powering industries from automotive to electronics. This dedicated news hub provides investors and professionals with timely updates on corporate developments, financial milestones, and technical innovations.
Access authoritative coverage of earnings announcements, strategic partnerships, and product advancements that shape Celanese's market leadership. Our curated collection features official press releases and third-party analysis of critical initiatives in polymer engineering, cellulose derivatives, and sustainable production methods.
Key updates include financial performance reports, manufacturing capacity expansions, and R&D breakthroughs in high-performance materials. Track the company's progress in addressing evolving demands across global markets while maintaining operational excellence in chemical engineering.
Bookmark this page for streamlined access to Celanese's latest business developments. Stay informed about the specialty materials sector through comprehensive coverage of CE's strategic positioning and industry impact.
Celanese Corporation (NYSE: CE) reported strong second quarter results with GAAP diluted earnings per share of $4.81 and record adjusted earnings per share of $5.02. The company achieved net sales of $2.2 billion, driven by an 18% increase in pricing and a 4% volume rise. Consolidated operating profit reached $567 million, with adjusted EBIT of $691 million. The acquisition of Santoprene™ is anticipated to enhance future earnings. Shareholder returns included $326 million in buybacks and dividends.
Celanese Corporation (NYSE: CE) announced the expansion of its Florence, Kentucky R&D center with a new Pharmaceutical Drug Delivery Feasibility Lab. This expansion aims to enhance development for long-acting controlled release drug delivery, showcasing Celanese's commitment to its Pharmaceutical segment. The lab will provide services such as material characterization and prototyping capabilities, facilitating quicker project advancements for pharmaceutical companies. With over 40 years in the medical market, Celanese aims to innovate drug delivery solutions and improve patient health outcomes.
Celanese Corporation (NYSE:CE) has approved a new $1.0 billion share repurchase authorization, representing approximately 6 percent of the company’s outstanding shares. In the first half of 2021, Celanese utilized $500 million to buy back shares from a previous $1.5 billion authorization. As of June 30, 2021, $560 million remained under that authorization. The addition of this new buyback program supports ongoing shareholder value enhancement.
Celanese Corporation (NYSE: CE) has declared a quarterly cash dividend of $0.68 per share, payable on August 9, 2021. Stockholders of record as of July 26, 2021 will receive the dividend. Celanese is a leading global chemical company with approximately 7,700 employees and reported $5.7 billion in net sales for 2020. The company focuses on differentiated chemistry solutions across various industries and aims to create shareholder value while positively impacting communities through The Celanese Foundation.
Celanese Corporation (NYSE: CE) will host a conference call on July 23, 2021, at 10:00 a.m. Eastern Time to discuss its second quarter 2021 results. The earnings release will be available after market close on July 22. Investors can access the webcast at Celanese Investors. A replay of the call will be accessible from July 23 until August 6, 2021. Celanese is a global leader in specialty materials, employing approximately 7,700 people, with 2020 net sales of $5.7 billion.
Celanese Corporation (NYSE: CE) has signed a definitive agreement to acquire the Santoprene™ TPV elastomers business from Exxon Mobil Corporation for $1.15 billion. This acquisition includes the Santoprene™, Dytron™, and Geolast™ brands, key production facilities, customer contracts, and a comprehensive intellectual property portfolio. Celanese expects the transaction to be accretive to its 2022 adjusted earnings per share and free cash flow. The acquisition aims to enhance Celanese's elastomers portfolio and drive shareholder value, focusing on growth in markets like mobility and sustainability.
Celanese Corporation (NYSE: CE) announced the acquisition of specific polyacetal (POM) production technology from Grupa Azoty S.A., which is discontinuing its POM manufacturing. The deal enables Celanese to serve existing Tarnoform® customers while leveraging its own assets. Although the transaction includes intellectual property and contracts, it does not encompass employees or manufacturing facilities from Azoty. Senior Vice President Tom Kelly highlighted the acquisition as a strategic move to enhance the growth of Celanese's Engineered Materials business. The closing is anticipated for early July 2021.
Celanese Corporation (NYSE: CE) reported first-quarter 2021 GAAP diluted earnings per share of $2.83, adjusted EPS of $3.46, and net sales of $1.8 billion, reflecting a 15% increase in pricing despite a 3% volume decline. Operating profit stood at $326 million, with adjusted EBIT at $482 million, both surpassing pre-COVID levels. The company faced challenges from Winter Storm Uri, incurring costs but maintaining momentum with a strong outlook of adjusted earnings of approximately $4.00 per share for Q2 2021. Celanese returned $328 million to shareholders through buybacks and dividends.
Celanese Corporation (NYSE: CE) announced a quarterly cash dividend of $0.68 per share on its common stock, set to be paid on May 10, 2021. Stockholders recorded as of April 26, 2021 are eligible for this dividend. Celanese is a global leader in chemical and specialty materials production, employing around 7,700 people worldwide and achieving $5.7 billion in net sales for 2020. The company aims to create value through its comprehensive chemistry and technology expertise.
Celanese Corporation (NYSE: CE) has announced a conference call scheduled for April 23, 2021, at 10:00 a.m. Eastern time, to discuss its first quarter 2021 results. The earnings press release will be available after the market closes on April 22, 2021. Interested participants can join via a hosted webcast or dial-in. The call will also be accessible for replay until May 7, 2021. In 2020, Celanese reported net sales of $5.7 billion and employs approximately 7,700 people globally.
